Biotech/Drug Stocks Q4 Earnings Due Feb 22: MRNA, BHC, NTLA, BMRN & More
Bausch Health(BHC) Zacks Investment Research·2024-02-21 23:16
We are in the last leg of the fourth-quarter 2023 reporting cycle and a lot of pharma and biotech bigwigs have already reported results. The picture looks reasonably good. Bellwether J&J reported strong fourth-quarter results, wherein its earnings and sales beat their respective estimates. Swiss pharma giant Novartis’ sales and earnings lagged their respective estimates.Among the biotechs, Biogen reported lower-than-expected results for the fourth quarter, as both its earnings and sales missed estimates. Gi ...